| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |